Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer

American Journal of Surgical Pathology

Volumn 23, Issue 3, 1999, Pages 296-301

  Ross, Jeffrey S ^a   Sheehan, Christine E ^a   Ambros, Robert A ^a   Nazeer, Tipu ^a   Jennings, Timothy A ^a   Kaufman Jr , Ronald P ^a   Fisher, Hugh A G ^b   Rifkin, Matthew D ^a   Kallakury, Bhaskar V S ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

DNA ploidy; Gleason grade; Gleason score; Prostate cancer; Radical prostatectomy

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; NEEDLE BIOPSY; PLOIDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

ADULT; AGED; BIOPSY, NEEDLE; DNA, NEOPLASM; HUMANS; IMAGE CYTOMETRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PLOIDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 0032979664     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199903000-00008     Document Type: Article

References (43)

1. Adolfsson J, Ronstrom L, Hedlund P-O, Lowhagen T, Carstensen J, Tribukait B. The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer. J Urol 1990;144:1404-7.
2. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long term survival among men with conservatively treated localized prostate cancer. JAMA 1995;274:626-31.
3. Bacus JW, Bacus JV. A method of correcting DNA ploidy measurements in tissue sections. Mod Pathol 1;94:6:652-64.
4. Bibbo M, Kim DH, Galera-Davidson H, di Lorteo C, Dytch HE. Architectural, morphometric and photometric features and their relationship to the main subjective diagnostic clues in the grading of prostatic cancer. Anal Quant Cytol Histol 1990;12:85-90.
5. Bibbo M, Kim DH, Pfeifer T, Dytch HE, Galera-Davidson H, Bartels PH. Histometric features for the grading of prostatic carcinoma. Anal Quant Cytol Histol 1991;13:61-8.
6. Bostwick DG. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol 1994;18:796-803.
7. Catalona WJ, Stein AJ, Fair WR. Grading errors in prostatic needle biopsies: relation to the accuracy of tumor grade in predicting pelvic lymph node metastases. J Urol 1982;127:919-22.
8. Dejter SW, Cunningham RE, Noguchi PD, et al. Prognostic significance of DNA ploidy in carcinoma of prostate. Urology 1989; 33:361-6.
9. di Lorteo C, Fitzpatrick B, Underhill S, et al. Correlation between visual clues, objective architectural features, and interobserver agreement in prostate cancer. Am J Clin Pathol 1991;96:70-5.
10. Epstein JI, Steinberg GD. The significance of low-grade prostate cancer on needle biopsy. A radical prostatectomy study of tumor grade, volume, and stage of the biopsied and multifocal tumor. Cancer 1990;66:1927-32.
11. Epstein JI, Pizov G, Steinberg GD, et al. Correlation of prostate cancer nuclear antigen deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy. J Urol 1992;148:87-91.
12. Epstein JI. The diagnosis and reporting of adenocarcinoma of the prostate in core needle biopsy specimens. Cancer 1996;78:350-6.
13. Fordham MVP, Burdge AH, Matthews J, Williams G, Cooke T. Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome. Br J Surg 1986;73:400-3.
14. Forsslund G, Nilsson B, Zetterberg A. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects. Cancer 1996;78: 1748-55.
15. Garnett JE, Oyasu R, Grayhack JT. The accuracy of diagnostic biopsy specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens. J Urol 1984;131: 690-3.
16. Gleason DF, Mellinger GT, Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
17. Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol 1992;23:273-9.
18. Huland H, Hammerer P, Henke R-P, Huland E. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal examination, prostate specific antigen and the results of six systematic biopsies. J Urol 1996;155:1344-7.
19. Humphrey PA, Walther PJ, Currin SM, Vollmer RT. Histologic grade, DNA ploidy, and intraglandular tumor extent as indicators of tumor progression in clinical stage B prostatic carcinoma. Am J Surg Pathol 1991;15:1165-70.
20. Kastendieck H. Morphologie des prostatacarcinomas in stanzbiopsien und totalen prostatektomien. Untersuchungen zur frage der relevanz bioptischer befundaussagen. Pathologic 1980;2:31-43.
21. Kojima M, Troncoso P, Babaian RJ. Use of prostate-specific antigen and tumor volume in predicting needle biopsy grading error. Urology 1995;45:807-12.
22. Lange PH, Narayan P. Understaging and undergrading of prostate cancer. Urology 1983;21:113-8.
23. Lessells AM, Burnett RA, Howatson SR, et al. Observer variability in histopathological reporting of needle biopsy specimens of the prostate. Hum Pathol 1997;28:646-9.
24. Leung CS, Zbieranowski I, Demers J, Murray D. DNA image cytometry of prostatic carcinoma: comparison of needle core biopsy and subsequent prostatectomy specimen. Mod Pathol 1994; 7:195-9.
25. Lieber MM, Murtaugh PA, Farrow GM, Myers RP, Blute ML. DNA ploidy and surgically treated prostate cancer. Important independent association with prognosis for patients with prostate carcinoma treated by radical prostatectomy. Cancer 1995;75: 1935-43.
26. Lundberg S, Carstensen J, Rundquist I. DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study. Cancer Res 1987;47:1973-7.
27. Mills SE, Fowler JE. Gleason histologic grading of prostatic carcinoma. Correlation between biopsy and prostatectomy specimens. Cancer 1986;57:346-9.
28. Montgomery BT, Nativ O, Blute M, et al. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis. Arch Surg 1990;125:327-31.
29. Nativ O, Winkler HC, Raz Y, et al. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. Mayo Clin Proc 1989;64:911-9.
30. Partin AW, Yoo J, Carter HB, et al. The use of prostate specific-antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150: 110-4.
31. Peller PA, Young DC, Marmaduke DP, Marsh WL, Badalament RA. Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens. Cancer 1995;75:530-8.
32. Peters-Gee JM, Miles BJ, Cerny JC, Gaba AR, Jacobsen G, Crissman JD. Prognostic significance of DNA quantitation in stage D1 prostate carcinoma with use of image analysis. Cancer 1992;70: 1159-65.
33. Pollack A, Zagars GK, El-Naggar AK, Gauwitz MD, Terry NHA. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy. Cancer 1994;73:1895-903.
34. Ritchie AWS, Layfield LJ, Lovrekovich H, Hannah J, Lovrekovich H, deKernion JB. Relationship of DNA content to conventional prognostic factors in clinically localized carcinoma of the prostate. Br J Urol 1988;62:254-60.
35. Ross JS, Nazeer T, Church K, et al. Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis. Cancer 1993;72: 3020-8.
36. Ross JS, Figge H, Bui HX, et al. Prediction of pathologic stage in postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer. Cancer 1994; 74:2811-8.
37. Spires SE, Cibull ML, Wood DP, Miller S, Spires SM, Banks ER. Gleason histologic grading in prostatic carcinoma. Correlation of 18-gauge core biopsy with prostatectomy. Arch Pathol Lab Med 1994;118:705-8.
38. Steinberg DM, Sauvageot J, Piantadosi S, Epstein JI. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 1997;21: 566-76.
39. Stephenson RA, James BC, Gay H, Fair WR, Whitmore WF Jr, Melamed MR. Flow cytometry of prostate cancer: relationship of DNA content to survival. Cancer Res 1987;47:2504-9.
40. Stotzka R, Manner R, Bartels PH, Thompson D. A hybrid neural and statistical classifier system for histopathologic grading of prostatic lesions. Anal Quant Cytol Histol 1995;17:204-18.
41. Tinari Nk, Natoli C, Angelucci D, et al. DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Cancer 1993;71: 1289-96.
42. van den Ouden D, Tribukait B, Blom JHM, et al. Deoxynbonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression. J Urol 1993;150: 400-406.
43. Winkler HZ, Rainwater LM, Myers RP, et al. Stage D 1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. Mayo Clin Proc 1988;63:103-12.